S. Aluwini

Androgen Deprivation therapy for Oligo-recurrent Prostate cancer in addition to radioTherapy (ADOPT): study protocol for a randomised phase III trial

E. Schuit, C. Brouwer, R. V. van Moorselaar, 2022, BMC Cancer.

Phase III randomised controlled trial on PSMA PET/CT guided hypofractionated salvage prostate bed radiotherapy of biochemical failure after radical prostatectomy for prostate cancer (PERYTON-trial): study protocol

E. Schuit, C. Brouwer, R. Smeenk, 2022, BMC cancer.

Recommendations for Radiation Therapy in Oligometastatic Prostate Cancer: an ESTRO-ACROP Delphi consensus.

M. Scorsetti, C. Belka, F. Alongi, 2022, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Role of Local and/or Metastasis-directed Therapy in Patients with Hormone-sensitive M1a Prostate Cancer-A Systematic Review.

A. Bergman, M. Donswijk, E. Wilthagen, 2022, European urology oncology.

Genetic Aspects and Molecular Testing in Prostate Cancer: A Report from a Dutch Multidisciplinary Consensus Meeting

Derya Yakar, J. Fütterer, R. V. D. van den Bergh, 2023, European urology open science.

Skeletal 18F-PSMA-1007 uptake in prostate cancer patients

J. Langendijk, W. Noordzij, I. D. de Jong, 2023, Therapeutic advances in medical oncology.

Simple immobilization for stereotactic radiotherapy aimed at pelvic metastases

J. Langendijk, C. Brouwer, S. Both, 2023, Physics and imaging in radiation oncology.

Target coverage and organs at risk dose in hypofractionated salvage radiotherapy after prostatectomy

J. Langendijk, C. Brouwer, S. Aluwini, 2024, Physics and imaging in radiation oncology.

Pelvic lymph node motion during cone-beam computed tomography guided stereotactic radiotherapy

S. Aluwini, J. Langendijk, J. Janssen, 2024, Clinical and translational radiation oncology.